Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
May-2018 Volume 39 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2018 Volume 39 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer

  • Authors:
    • Heae Surng Park
    • Byung Chang Kim
    • Hyun Yang Yeo
    • Kyung-Hee Kim
    • Byong Chul Yoo
    • Ji Won Park
    • Hee Jin Chang
  • View Affiliations / Copyright

    Affiliations: Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Republic of Korea, Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang-si 10408, Republic of Korea, Research Institute, National Cancer Center, Goyang-si 10408, Republic of Korea, Department of Surgery, Seoul National University College of Medicine, Seoul 03080, Republic of Korea, Department of Pathology and Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang-si 10408, Republic of Korea
  • Pages: 2279-2287
    |
    Published online on: March 1, 2018
       https://doi.org/10.3892/or.2018.6287
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The gene deleted in malignant brain tumor 1 (DMBT1) encoding a large scavenger receptor cysteine-rich protein was originally identified based on its deletion in a brain tumor cell line. The DMBT1 protein is involved in mucosal immune defense, epithelial differentiation and tumor suppression. In the present study, the clinicopathologic significance of DMBT1 protein expression in stool and tissue samples of colorectal cancer (CRC) patients was evaluated. Western blot analysis of fecal DMBT1 was performed for patients with CRC (n=177), colorectal adenoma (n=61), inflammatory bowel diseases (IBDs; n=54) and healthy individuals as the control group (n=151). Immunohistochemical analysis of tissue expression of DMBT1 was performed in 385 primary CRC tissues. Fecal DMBT1 expression was higher in CRC and IBD patients than in healthy controls or adenoma patients (P<0.0001), but not significantly different between IBD and CRC or between adenoma and healthy control groups. In CRC patients, fecal DMBT1 expression was not associated with the tumor stage or site. The sensitivity of fecal DMBT1 analysis for CRC was 50%, while the specificity and positive predictive value were 86.8 and 81.3%, respectively. Immunohistochemical expression patterns of DMBT1 in CRC tissues varied from loss to overexpression. Loss of expression was observed in 4.7% (18 out of 385 cases) and significantly associated with lymph node metastasis (P=0.016), distant metastasis (P=0.013), advanced stage (P=0.026), and higher histologic grade (P=0.033). In addition, DMBT1 loss was an independent poor prognostic factor for cancer-associated death (hazard ratio, 2.272; P=0.015) and disease recurrence (hazard ratio, 2.689; P=0.009). In conclusion, fecal DMBT1 has limited value as a diagnostic biomarker, while the tissue expression of DMBT1 may serve as an efficient prognostic marker for CRC. Furthermore, DMBT1 may have a role in the progression of CRC.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH and Lee KH: Community of Population-Based Regional Cancer Registries: Cancer Statistics in Korea: Incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat. 49:292–305. 2017. View Article : Google Scholar : PubMed/NCBI

3 

Rhodes JM: Colorectal cancer screening in the UK: Joint position statement by the British Society of Gastroenterology, The Royal College of Physicians, and The Association of Coloproctology of Great Britain and Ireland. Gut. 46:746–748. 2000. View Article : Google Scholar : PubMed/NCBI

4 

Kim BC, Joo J, Chang HJ, Yeo HY, Yoo BC, Park B, Park JW, Sohn DK, Hong CW and Han KS: A predictive model combining fecal calgranulin B and fecal occult blood tests can improve the diagnosis of colorectal cancer. PLoS One. 9:e1061822014. View Article : Google Scholar : PubMed/NCBI

5 

Yoo BC, Shin YK, Lim SB, Hong SH, Jeong SY and Park JG: Evaluation of calgranulin B in stools from the patients with colorectal cancer. Dis Colon Rectum. 51:1703–1709. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, von Deimling A and Poustka A: DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumours. Nat Genet. 17:32–39. 1997. View Article : Google Scholar : PubMed/NCBI

7 

Ligtenberg TJ, Bikker FJ, Groenink J, Tornoe I, Leth-Larsen R, Veerman EC, Amerongen Nieuw AV and Holmskov U: Human salivary agglutinin binds to lung surfactant protein-D and is identical with scavenger receptor protein gp-340. Biochem J. 359:243–248. 2001. View Article : Google Scholar : PubMed/NCBI

8 

Ligtenberg AJ, Karlsson NG and Veerman EC: Deleted in malignant brain tumors-1 protein (DMBT1): A pattern recognition receptor with multiple binding sites. Int J Mol Sci. 11:5212–5233. 2010. View Article : Google Scholar : PubMed/NCBI

9 

Madsen J, Mollenhauer J and Holmskov U: Review: Gp-340/DMBT1 in mucosal innate immunity. Innate Immun. 16:160–167. 2010. View Article : Google Scholar : PubMed/NCBI

10 

Vijayakumar S, Takito J, Hikita C and Al-Awqati Q: Hensin remodels the apical cytoskeleton and induces columnarization of intercalated epithelial cells: Processes that resemble terminal differentiation. J Cell Biol. 144:1057–1067. 1999. View Article : Google Scholar : PubMed/NCBI

11 

Cheng H, Bjerknes M and Chen H: CRP-ductin: A gene expressed in intestinal crypts and in pancreatic and hepatic ducts. Anat Rec. 244:327–343. 1996. View Article : Google Scholar : PubMed/NCBI

12 

Holmskov U, Mollenhauer J, Madsen J, Vitved L, Gronlund J, Tornoe I, Kliem A, Reid KB, Poustka A and Skjodt K: Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci USA. 96:10794–10799. 1999. View Article : Google Scholar : PubMed/NCBI

13 

Madsen J, Sorensen GL, Nielsen O, Tornøe I, Thim L, Fenger C, Mollenhauer J and Holmskov U: A variant form of the human deleted in malignant brain tumor 1 (DMBT1) gene shows increased expression in inflammatory bowel diseases and interacts with dimeric trefoil factor 3 (TFF3). PLoS One. 8:e644412013. View Article : Google Scholar : PubMed/NCBI

14 

Garay J, Piazuelo MB, Lopez-Carrillo L, Leal YA, Majumdar S, Li L, Cruz-Rodriguez N, Serrano-Gomez SJ, Busso CS, Schneider BG, et al: Increased expression of deleted in malignant brain tumors (DMBT1) gene in precancerous gastric lesions: Findings from human and animal studies. Oncotarget. 8:47076–47089. 2017. View Article : Google Scholar : PubMed/NCBI

15 

Mollenhauer J, Holmskov U, Wiemann S, Krebs I, Herbertz S, Madsen J, Kioschis P, Coy JF and Poustka A: The genomic structure of the DMBT1 gene: Evidence for a region with susceptibility to genomic instability. Oncogene. 18:6233–6240. 1999. View Article : Google Scholar : PubMed/NCBI

16 

Wu W, Kemp BL, Proctor ML, Gazdar AF, Minna JD, Hong WK and Mao L: Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. Cancer Res. 59:1846–1851. 1999.PubMed/NCBI

17 

Mori M, Shiraishi T, Tanaka S, Yamagata M, Mafune K, Tanaka Y, Ueo H, Barnard GF and Sugimachi K: Lack of DMBT1 expression in oesophageal, gastric and colon cancers. Br J Cancer. 79:211–213. 1999. View Article : Google Scholar : PubMed/NCBI

18 

Braidotti P, Nuciforo PG, Mollenhauer J, Poustka A, Pellegrini C, Moro A, Bulfamante G, Coggi G, Bosari S and Pietra GG: DMBT1 expression is down-regulated in breast cancer. BMC Cancer. 4:462004. View Article : Google Scholar : PubMed/NCBI

19 

Mueller W, Mollenhauer J, Stockhammer F, Poustka A and von Deimling A: Rare mutations of the DMBT1 gene in human astrocytic gliomas. Oncogene. 21:5956–5959. 2002. View Article : Google Scholar : PubMed/NCBI

20 

Mollenhauer J, Herbertz S, Holmskov U, Tolnay M, Krebs I, Merlo A, Schrøder HD, Maier D, Breitling F, Wiemann S, et al: DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res. 60:1704–1710. 2000.PubMed/NCBI

21 

Conde AR, Martins AP, Brito M, Manuel A, Ramos S, Malta-Vacas J, Renner M, Poustka A, Mollenhauer J and Monteiro C: DMBT1 is frequently downregulated in well-differentiated gastric carcinoma but more frequently upregulated across various gastric cancer types. Int J Oncol. 30:1441–1446. 2007.PubMed/NCBI

22 

Mollenhauer J, Helmke B, Müller H, Kollender G, Lyer S, Diedrichs L, Holmskov U, Ligtenberg T, Herbertz S, Krebs I, et al: Sequential changes of the DMBT1 expression and location in normal lung tissue and lung carcinomas. Genes Chromosomes Cancer. 35:164–169. 2002. View Article : Google Scholar : PubMed/NCBI

23 

World Health Organization, . WHO Classification of Tumours of the Digestive SystemBosman FT, Carneiro F, Hruban RH and Theise ND: 3. 4th. IARC; Lyon: 2010

24 

American Joint Committee on Cancer: AJCC Cancer Staging Atlas. Greene FL, Compton CC, Fritz AG, Shah JP and Winchester DP: Springer; New York: 2006, doi: org/10.1007/0-387-33126-3.

25 

Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H and Chejfec G: Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 343:162–168. 2000. View Article : Google Scholar : PubMed/NCBI

26 

Yao T, Matsui T and Hiwatashi N: Crohn's disease in Japan: Diagnostic criteria and epidemiology. Dis Colon Rectum. 43 Suppl:S85–S93. 2000. View Article : Google Scholar : PubMed/NCBI

27 

Choi CH, Jung SA, Lee BI, Lee KM, Kim JS and Han DS: IBD Study Group of the Korean Association of the Study of Intestinal Diseases: Diagnostic guideline of ulcerative colitis. Korean J Gastroenterol. 53:145–160. 2009.(In Korean). PubMed/NCBI

28 

Ye BD, Jang BI, Jeen YT, Lee KM, Kim JS and Yang SK: IBD Study Group of the Korean Association of the Study of Intestinal Diseases: Diagnostic guideline of Crohn's disease. Korean J Gastroenterol. 53:161–176. 2009.(In Korean). PubMed/NCBI

29 

Telakis E and Tsironi E: Indeterminate colitis-definition, diagnosis, characteristics and management. Ann Gastroenterol. 21:173–180. 2009.

30 

Foell D, Wittkowski H and Roth J: Monitoring disease activity by stool analyses: From occult blood to molecular markers of intestinal inflammation and damage. Gut. 58:859–868. 2009. View Article : Google Scholar : PubMed/NCBI

31 

Rosenstiel P, Sina C, End C, Renner M, Lyer S, Till A, Hellmig S, Nikolaus S, Fölsch UR, Helmke B, et al: Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion. J Immunol. 178:8203–8211. 2007. View Article : Google Scholar : PubMed/NCBI

32 

Mollenhauer J, Helmke B, Müller H, Kollender G, Krebs I, Wiemann S, Holmskov U, Madsen J, Otto HF and Poustka A: An integrative model on the role of DMBT1 in epithelial cancer. Cancer Detect Prev. 26:266–274. 2002. View Article : Google Scholar : PubMed/NCBI

33 

Goeppert B, Roessler S, Becker N, Zucknick M, Vogel MN, Warth A, Pathil-Warth A, Mehrabi A, Schirmacher P, Mollenhauer J, et al: DMBT1 expression in biliary carcinogenesis with correlation of clinicopathological data. Histopathology. 70:1064–1071. 2017. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Park H, Kim B, Yeo H, Kim K, Yoo B, Park J and Chang H: Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer. Oncol Rep 39: 2279-2287, 2018.
APA
Park, H., Kim, B., Yeo, H., Kim, K., Yoo, B., Park, J., & Chang, H. (2018). Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer. Oncology Reports, 39, 2279-2287. https://doi.org/10.3892/or.2018.6287
MLA
Park, H., Kim, B., Yeo, H., Kim, K., Yoo, B., Park, J., Chang, H."Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer". Oncology Reports 39.5 (2018): 2279-2287.
Chicago
Park, H., Kim, B., Yeo, H., Kim, K., Yoo, B., Park, J., Chang, H."Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer". Oncology Reports 39, no. 5 (2018): 2279-2287. https://doi.org/10.3892/or.2018.6287
Copy and paste a formatted citation
x
Spandidos Publications style
Park H, Kim B, Yeo H, Kim K, Yoo B, Park J and Chang H: Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer. Oncol Rep 39: 2279-2287, 2018.
APA
Park, H., Kim, B., Yeo, H., Kim, K., Yoo, B., Park, J., & Chang, H. (2018). Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer. Oncology Reports, 39, 2279-2287. https://doi.org/10.3892/or.2018.6287
MLA
Park, H., Kim, B., Yeo, H., Kim, K., Yoo, B., Park, J., Chang, H."Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer". Oncology Reports 39.5 (2018): 2279-2287.
Chicago
Park, H., Kim, B., Yeo, H., Kim, K., Yoo, B., Park, J., Chang, H."Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer". Oncology Reports 39, no. 5 (2018): 2279-2287. https://doi.org/10.3892/or.2018.6287
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team